BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10541970)

  • 1. Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts.
    Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Watanabe N; Shuke N; Aburano T; Takayama T; Michigishi T; Tonami N
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):630-6. PubMed ID: 10541970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.
    Blumenthal RD; Sharkey RM; Natale AM; Kashi R; Wong G; Goldenberg DM
    Cancer Res; 1994 Jan; 54(1):142-51. PubMed ID: 8261435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced efficacy of radioimmunotherapy combined with systemic chemotherapy and local hyperthermia in xenograft model.
    Kinuya S; Yokoyama K; Konishi S; Hiramatsu T; Watanabe N; Shuke N; Aburano T; Takayama T; Michigishi T; Tonami N
    Jpn J Cancer Res; 2000 May; 91(5):573-8. PubMed ID: 10835504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells.
    Li XF; Kinuya S; Yokoyama K; Koshida K; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1669-74. PubMed ID: 12458402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer.
    Stein R; Juweid M; Zhang CH; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3199s-3206s. PubMed ID: 10541364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
    Stein R; Chen S; Reed L; Richel H; Goldenberg DM
    Cancer; 2002 Jan; 94(1):51-61. PubMed ID: 11815960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
    Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W
    Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy.
    Modrak DE; Gold DV; Goldenberg DM; Blumenthal RD
    Tumour Biol; 2003; 24(1):32-9. PubMed ID: 12743424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination radioimmunotherapy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts.
    Kinuya S; Yokoyama K; Hiramatsu T; Tega H; Tanaka K; Konishi S; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
    Cancer Lett; 1999 Jun; 140(1-2):209-18. PubMed ID: 10403561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
    Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
    Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.
    Blumenthal RD; Taylor A; Osorio L; Ochakovskaya R; Raleigh JA; Papadopoulou M; Bloomer WD; Goldenberg DM
    Int J Cancer; 2001 Nov; 94(4):564-71. PubMed ID: 11745445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma.
    Sharkey RM; Blumenthal RD; Behr TM; Wong GY; Haywood L; Forman D; Griffiths GL; Goldenberg DM
    Int J Cancer; 1997 Jul; 72(3):477-85. PubMed ID: 9247292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenografts.
    Blumenthal RD; Sharkey RM; Kashi R; Sides K; Stein R; Goldenberg DM
    Tumour Biol; 1997; 18(6):367-77. PubMed ID: 9372870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer.
    Kinuya S; Yokoyama K; Izumo M; Sorita T; Obata T; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
    J Cancer Res Clin Oncol; 2003 Jul; 129(7):392-6. PubMed ID: 14605881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts.
    Kinuya S; Yokoyama K; Kawashima A; Hiramatsu T; Konishi S; Shuke N; Watanabe N; Takayama T; Michigishi T; Tonami N
    J Nucl Med; 2000 Jul; 41(7):1244-9. PubMed ID: 10914917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy.
    Blumenthal RD; Lew W; Reising A; Soyne D; Osorio L; Ying Z; Goldenberg DM
    Int J Cancer; 2000 Apr; 86(2):276-80. PubMed ID: 10738257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.
    Chalandon Y; Mach JP; Pèlegrin A; Folli S; Buchegger F
    Anticancer Res; 1992; 12(4):1131-9. PubMed ID: 1503403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.